TCNNF - Trulieve Cannabis Corp.


6.15
0.150   2.439%

Share volume: 145,297
Last Updated: 03-03-2026
Pharmaceutical Products/Medicinal Chemicals: 2.32%

PREVIOUS CLOSE
CHG
CHG%

$6.00
0.15
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
92%
Profitability 100%
Dept financing 50%
Liquidity 68%
Performance 100%
Company vs Stock growth
vs
Performance
5 Days
2.50%
1 Month
-10.09%
3 Months
1.49%
6 Months
-18.87%
1 Year
37.58%
2 Year
2.66%
Key data
Stock price
$6.15
P/E Ratio 
0.00
DAY RANGE
$5.84 - $6.18
EPS 
-$0.75
52 WEEK RANGE
$3.02 - $11.83
52 WEEK CHANGE
$48.19
MARKET CAP 
1.663 B
YIELD 
N/A
SHARES OUTSTANDING 
192.307 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$229,747
AVERAGE 30 VOLUME 
$217,719
Company detail
CEO: N/A
Region: US
Website: trulieve.com
Employees: 9,000
IPO year: 2018
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.

Recent news